Roche employees at more than 120 company sites around the world have been showing their solidarity with children in need by raising funds through sponsored walks. The donations will be used to support day-care centers for orphans and educational initiatives in Malawi, as well as children's charities in their own countries.

Pfizer Inc. (NYSE:PFE) and Cellectis (Paris:ALCLS) have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.

Pfizer Inc. (NYSE:PFE) has announced the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass. The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and position Pfizer in closer proximity to leading academic institutions, hospitals and patient organizations.

Mindprint Inc. and Ockham Development, Inc. have implemented an innovative automation software system to help the global CRO manage trials efficiently to ensure a more focused approach to its core oncology mission.

Sanofi (EURONEXT: SAN and NYSE: SNY) and Eli Lilly and Company (NYSE: LLY) have announced an agreement to pursue regulatory approval of nonprescription Cialis (tadalafil). Cialis is currently available by prescription only worldwide for the treatment of men with erectile dysfunction (ED).

Bristol-Myers Squibb (NYSE:BMY) and Syngene International, India's largest contract research organization, have announced a five-year extension of their drug discovery and development collaboration in India. Financial terms were not disclosed.

AstraZeneca provided an update on the rapid development of its oncology pipeline at a briefing for analysts and investors on 2 June 2014, as compelling data from over 40 scientific abstracts related to AstraZeneca and MedImmune investigational medicines were presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago.